Matthew H W, Salley S O, Peterson W D, Klein M D
Department of Chemical Engineering, College of Engineering, Wayne State University, Detroit, Michigan 48202.
Biotechnol Prog. 1993 Sep-Oct;9(5):510-9. doi: 10.1021/bp00023a010.
A number of combinations of anionic and cationic polymers, the majority being polysaccharides, were screened to determine their suitability for the development of alternative microcapsule formulations capable of supporting cells. The capsules were taken through a limited optimization and then evaluated on the bases of rupture strength, permeability to albumin, and ability of their components to promote the attachment, aggregation, and function of encapsulated rabbit hepatocytes. The widely used alginate-polylysine capsules were employed as a comparative standard in all tests. A number of the new formulations compared favorably with the standard, and some exhibited superior performance in specific areas. Hepatocyte function, as evaluated by the rate of urea synthesis, showed no significant differences between formulations over a 24-h test period. One formulation, composed of the polysaccharides (carboxymethyl)cellulose, chondroitin sulfate A, chitosan, and polygalacturonate, was found to be superior to alginate-polylysine capsules in the areas investigated and supported the long-term survival and growth of liver endothelial cells.
对多种阴离子和阳离子聚合物的组合进行了筛选,其中大多数是多糖,以确定它们是否适合开发能够支持细胞生长的替代微胶囊制剂。对这些胶囊进行了有限的优化,然后根据破裂强度、对白蛋白的渗透性以及其成分促进包封的兔肝细胞附着、聚集和功能的能力进行评估。在所有测试中,广泛使用的海藻酸盐-聚赖氨酸胶囊被用作比较标准。许多新制剂与标准制剂相比表现良好,有些在特定方面表现出卓越性能。通过尿素合成速率评估的肝细胞功能在24小时测试期内各制剂之间没有显著差异。发现一种由多糖(羧甲基)纤维素、硫酸软骨素A、壳聚糖和聚半乳糖醛酸组成的制剂在所研究的方面优于海藻酸盐-聚赖氨酸胶囊,并支持肝内皮细胞的长期存活和生长。